Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Changes made to FP10 prescriptions and tokens

The reverse of all FP10 prescriptions and tokens have now been changed with an aim to help patients and pharmacy teams to easily determine the eligibility for exemption from prescription charges.

This is part of the recent introduction of new NHS prescription forms and EPS Tokens in England.


The new FP10 forms (FP10SS, FP10D, FP10PN, etc.) and tokens (FP10DT) are now in circulation and pharmacy teams are expected to see these being presented by patients in the coming weeks.

Key changes include:

  • Addition of new exemption box ‘U’ for patients who are in receipt of “Universal Credit and meets the criteria
  • Removal of box ‘X’ for “was prescribed free-of-charge contraceptives
  • Introduction of a new prescriber endorsement ‘FS’ for “free supply of sexual health treatment
  • Merging of age exemption categories (‘A’ and ‘C’) into a single category ‘A’ for “is 60 years of age or over or is under 16 years of age
  • Re-wording of exemption category ‘G’ to “Prescription exemption certificate issued by the Ministry of Defence

The Pharmaceutical Services Negotiating Committee (PSNC) reminded that pharmacists can accept both existing and new versions of FP10 forms and tokens for dispensing as the existing version will remain in circulation until their stocks are exhausted.

PSNC Drug Tariff and Reimbursement Manager, Suraj Shah, said: “Pharmacy teams regularly help patients to identify whether they are eligible for free NHS prescriptions, but this can be a time-consuming process in a busy environment. PSNC hopes that these changes – particularly the long-awaited addition of a specific exemption box for Universal Credit claimants – will help make claiming exemptions more straightforward, consequently reducing the risk of penalty charges and prescription switching.”

“Removing the requirement for patients to sign the reverse of their prescription/Token for contraceptives will also reduce the administrative burden on pharmacies, who will no longer need to submit these EPS Tokens to the NHS Business Services Authority. However, we are keen to see these changes being applied to EPS prescribing and dispensing systems as soon as possible to bring them into line with the new paper forms and Tokens,” he said.

Pharmacists are also advised to review and update their SOPs to ensure accurate completion of patient declarations on the new version of the FP10 forms and tokens.

More For You

B&S Group has mourned the death of Ketan Shah in the Air India plane crash in India last week

B&S Group has mourned the death of Ketan Shah in the Air India plane crash in India last week

LinkedIn

B&S Group mourns the death of Ketan Shah in Air India crash

Pharmaceutical Supplier B&S Group has mourned the death of Ketan Shah in the Air India plane crash in India last week.

A post on the company's LinkedIn page stated, "Ketan was not just a valued part of the B&S Group family; he was a bright light in every room, known for his warmth, integrity, and unwavering positivity. His legacy remains in the friendships he nurtured and the lives he touched."

Keep ReadingShow less
NHS app to boost clinical trials

The focus is on encouraging people from underrepresented groups, including minorities from African and Asian heritage, to sign up for clinical trials.

iStock

Government to use NHS app to boost clinical trials

The government’s 10-Year Health Plan is expected to provide a fillip to clinical trials, and it plans to make use of the NHS App to encourage people to sign up as participants.

People will be able to sign up for the NIHR Be Part of Research service (bepartofresearch.uk) on the NHS App for the trials best suited to their interests and needs.

Keep ReadingShow less
US pharma bets big on China to snap up potential blockbuster drugs

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies

US pharma bets big on China to snap up potential blockbuster drugs

US drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments.

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies. That compares with just two such deals in the year-earlier period, according to data from GlobalData provided exclusively to Reuters.

Keep ReadingShow less
Alliance Healthcare team raises thousands with charity bike ride to Paris

The Alliance Healthcare team

Alliance Healthcare team raises thousands with charity bike ride to Paris

Eight Alliance Healthcare team members raised over £55,000 for Theodora Children’s Charity by cycling from Surrey to Paris.

From June 13th-15th, the team took on the gruelling 300 mile cross-border Tour D’Alliance 2025 challenge and raised vital funds to support children who may be living with serious health challenges through Theodora Children’s Charity’s Giggle Doctor programme.

Keep ReadingShow less
Over four million flu vaccines across England in the 2024/25 winter flu season.

Over four million flu vaccines across England in the 2024/25 winter flu season.

CCA release

Community pharmacy administered over four million flu vaccines

Community pharmacy administered over four million flu vaccines across England in the 2024/25 winter flu season, the highest outside of the pandemic, according to the Company Chemists’ Association.

This is nearly 10 per cent higher than the number of flu vaccines administered in 2023/24.

Keep ReadingShow less